Leonel Vargas-Jaimes1, Liang Xiao2,3, Jing Zhang2, Lourival D Possani1, Héctor H Valdivia3, Verónica Quintero-Hernández1,4. 1. Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos 62271, México. 2. Department of Marine Biotechnology, Faculty of Naval Medicine, Second Military Medical University, Shanghai, 200433, China. 3. Center for Arrhythmia Research, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA. 4. CONACYT- Laboratorio de Ecología Molecular Microbiana, Centro de Investigaciones en Ciencias Microbiológicas-Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Ciudad Universitaria, C.P. 72570, Puebla, México.
Abstract
BACKGROUND: Scorpion venoms contain toxins that modulate ionic channels, among which are the calcins, a small group of short, basic peptides with an Inhibitor Cystine Knot (ICK) motif that target calcium release channels/ryanodine receptors (RyRs) with high affinity and selectivity. Here we describe the heterologous expression of Intrepicalcin, identified by transcriptomic analysis of venomous glands from Vaejovis intrepidus. METHODS: Recombinant Intrepicalcin was obtained in Escherichia coli BL21-DE3 (periplasm) by fusing the Intrepicalcin gene to sequences coding for signal-peptide, thioredoxin, His-tag and enterokinase cleavage site. RESULTS: [3H]Ryanodine binding, used as a functional index of RyR activity, revealed that recombinant Intrepicalcin activates skeletal RyR (RyR1) dose-dependently with Kd=17.4±4.0nM. Intrepicalcin significantly augments the bell-shaped [Ca2+]-[3H]ryanodine binding curve at all [Ca2+] ranges, as is characteristic of the calcins. In single channel recordings, Intrepicalcin induces the appearance of a subconductance state in RyR1 with a fractional value ∼55% of the full conductance state, very close to that of Vejocalcin. Furthermore, Intrepicalcin stimulates Ca2+ release at an initial dose=45.3±2.5nM, and depletes ~50% of Ca2+ load from skeletal sarcoplasmic reticulum vesicles. CONCLUSIONS: We conclude that active recombinant Intrepicalcin was successfully obtained without the need of manual oxidation, enabling it to target RyR1s with high affinity. GENERAL SIGNIFICANCE: This is the first calcin heterologously expressed in the periplasma of Escherichia coli BL21-DE3, shown to be pharmacologically effective, thus paving the way for the generation of Intrepicalcin variants that are required for structure-function relationship studies of calcins and RyRs.
BACKGROUND: Scorpion venoms contain toxins that modulate ionic channels, among which are the calcins, a small group of short, basic peptides with an Inhibitor Cystine Knot (ICK) motif that target calcium release channels/ryanodine receptors (RyRs) with high affinity and selectivity. Here we describe the heterologous expression of Intrepicalcin, identified by transcriptomic analysis of venomous glands from Vaejovis intrepidus. METHODS: Recombinant Intrepicalcin was obtained in Escherichia coli BL21-DE3 (periplasm) by fusing the Intrepicalcin gene to sequences coding for signal-peptide, thioredoxin, His-tag and enterokinase cleavage site. RESULTS:[3H]Ryanodine binding, used as a functional index of RyR activity, revealed that recombinant Intrepicalcin activates skeletal RyR (RyR1) dose-dependently with Kd=17.4±4.0nM. Intrepicalcin significantly augments the bell-shaped [Ca2+]-[3H]ryanodine binding curve at all [Ca2+] ranges, as is characteristic of the calcins. In single channel recordings, Intrepicalcin induces the appearance of a subconductance state in RyR1 with a fractional value ∼55% of the full conductance state, very close to that of Vejocalcin. Furthermore, Intrepicalcin stimulates Ca2+ release at an initial dose=45.3±2.5nM, and depletes ~50% of Ca2+ load from skeletal sarcoplasmic reticulum vesicles. CONCLUSIONS: We conclude that active recombinant Intrepicalcin was successfully obtained without the need of manual oxidation, enabling it to target RyR1s with high affinity. GENERAL SIGNIFICANCE: This is the first calcin heterologously expressed in the periplasma of Escherichia coli BL21-DE3, shown to be pharmacologically effective, thus paving the way for the generation of Intrepicalcin variants that are required for structure-function relationship studies of calcins and RyRs.
Authors: Georgina B Gurrola; Rogelio A Hernández-López; Ricardo C Rodríguez de la Vega; Zoltan Varga; Cesar V F Batista; Saida P Salas-Castillo; Gyorgy Panyi; Federico del Río-Portilla; Lourival D Possani Journal: Biochemistry Date: 2012-05-07 Impact factor: 3.162
Authors: Angela F Dulhunty; Suzanne M Curtis; Sarah Watson; Louise Cengia; Marco G Casarotto Journal: J Biol Chem Date: 2003-12-29 Impact factor: 5.157
Authors: Karen Luna-Ramírez; Veronica Quintero-Hernández; Leonel Vargas-Jaimes; Cesar V F Batista; Kenneth D Winkel; Lourival D Possani Journal: Toxicon Date: 2012-11-23 Impact factor: 3.033
Authors: Liang Xiao; Georgina B Gurrola; Jing Zhang; Carmen R Valdivia; Mario SanMartin; Fernando Z Zamudio; Liming Zhang; Lourival D Possani; Héctor H Valdivia Journal: J Gen Physiol Date: 2016-05 Impact factor: 4.086
Authors: Alaa M H El-Bitar; Moustafa Sarhan; Mohamed A Abdel-Rahman; Veronica Quintero-Hernandez; Chie Aoki-Utsubo; Mohsen A Moustafa; Lourival D Possani; Hak Hotta Journal: Int J Pept Res Ther Date: 2019-07-06 Impact factor: 1.931
Authors: Teresa Romero-Gutierrez; Esteban Peguero-Sanchez; Miguel A Cevallos; Cesar V F Batista; Ernesto Ortiz; Lourival D Possani Journal: Toxins (Basel) Date: 2017-12-12 Impact factor: 4.546